Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking
Clinical trial NCT00218465 · COMPLETED
Trial details
- NCT number
- NCT00218465
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2009-06-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.